UGT1A1 and Crigler-Najjar syndrome: The iPSC-derived cortical organoids employed in this study represent a Crigler–Najjar syndrome model to study defective UGT1A1 and its subsequent phenotypic manifestation and potential application for future BIND-associated toxicological studies and drug screening.